Trial intelligence / Profile preview

Sildenafil for PH in HFpEF

NCT01156636Phase 3Completed

Sponsor
University of Milan
Start
Jan 2006
Primary completion
Sep 2009
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial in pulmonary hypertension (PH) comparing Sildenafil with Placebo (2 arms). Primary endpoint: Pulmonary hemodynamics at 1 year. Started Jan 2006; status: completed.

02

Drugs

sildenafil
03

Conditions

pulmonary hypertension (PH)

Beyond the preview

Go deeper on NCT01156636.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01156636.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call